Rare diseases
Investigational molecules
Locations
Back to Czechia544 clinical trials in Novy Jicin, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on the Effects of KBP-336 and Paracetamol for Obese Patients with Knee Osteoarthritis
CzechiaStudy on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer
CzechiaStudy Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma
CzechiaStudy on Istaroxime for Patients with Cardiogenic Shock Stage C
CzechiaStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
CzechiaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
CzechiaStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
CzechiaStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
CzechiaStudy on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis
CzechiaStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on various types of cancer, including non-small cell lung cancer, breast cancer, and prostate cancer. Studies are evaluating novel combination therapies and treatment approaches for advanced stages of disease.
Emphasis on targeted therapies and immunotherapy combinations for improved patient outcomes.
Comprehensive research into skin conditions, particularly plaque psoriasis and atopic dermatitis. Trials are investigating long-term safety and efficacy of new therapeutic agents.
Focus on developing sustainable treatment options for chronic skin conditions.
Diverse research portfolio including studies in nephrology, gastroenterology, and rheumatology. Trials examining innovative treatments for conditions such as IgA nephropathy and short bowel syndrome.
Investigating targeted therapies for complex medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
